News

Hilleman Laboratories is committed to developing high impact, affordable vaccines for people in developing countries in an innovative and sustainable manner.

Merck JV Looking at New Rotavirus Vaccine for Poor

Date: 25/01/2011

Merck to Fund Rotavirus Vaccine Project

Date: 25/01/2011

Hilleman Lab to Invest About Rs 650 Cr to Develop Vaccines

Date: 25/01/2011

Hilleman Laboratories Project Aims to Assess..

Date: 25/01/2011